BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 19175902)

  • 1. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
    Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
    Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.
    Burdick J; Chase HP; Slover RH; Knievel K; Scrimgeour L; Maniatis AK; Klingensmith GJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):e221-4. PubMed ID: 14993580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HbA1c to BOLUS Scores Among Youths with Type 1 Diabetes.
    Clements MA; DeLurgio SA; Williams DD; Habib S; Halpin K; Patton SR
    Diabetes Technol Ther; 2016 Jun; 18(6):351-9. PubMed ID: 27258122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.
    Davidson PC; Hebblewhite HR; Steed RD; Bode BW
    Endocr Pract; 2008 Dec; 14(9):1095-101. PubMed ID: 19158048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Automatic Carbohydrate, Protein, Fat and Calorie Counting Based on Voice Descriptions of Meals in People with Type 1 Diabetes.
    Ladyzynski P; Krzymien J; Foltynski P; Rachuta M; Bonalska B
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII.
    Anderson DG
    Pediatr Diabetes; 2009 Aug; 10(5):304-9. PubMed ID: 19076301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with type 1 diabetes mellitus.
    Patton SR; Clements MA; Fridlington A; Cohoon C; Turpin AL; Delurgio SA
    Diabetes Technol Ther; 2013 Feb; 15(2):124-8. PubMed ID: 23317372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes.
    Pańkowska E; Skórka A; Szypowska A; Lipka M
    Diabetes Technol Ther; 2005 Apr; 7(2):308-14. PubMed ID: 15857233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.
    Olinder AL; Kernell A; Smide B
    Pediatr Diabetes; 2009 Apr; 10(2):142-8. PubMed ID: 19175898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
    Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study.
    Pańkowska E; Błazik M; Groele L
    Diabetes Technol Ther; 2012 Jan; 14(1):16-22. PubMed ID: 22013887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.
    Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP
    Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.
    King AB
    Endocr Pract; 2009; 15(4):383. PubMed ID: 19502212
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
    Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
    Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Maltoni G; Allen JM; Nodale M; Kumareswaran K; Leelarathna L; Thabit H; Caldwell K; Wilinska ME; Calhoun P; Kollman C; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2014 Nov; 16(11):1174-8. PubMed ID: 24909206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus.
    Deeb A; Abu-Awad S; Abood S; El-Abiary M; Al-Jubeh J; Yousef H; AbdelRahman L; Al Hajeri A; Mustafa H
    Diabetes Technol Ther; 2015 Mar; 17(3):166-70. PubMed ID: 25513744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
    King AB
    Endocr Pract; 2009 Apr; 15(3):229-33. PubMed ID: 19364691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.